Skip to main content

Replimune Group Inc

For the period ended Jun 30, 2024. Filed Aug 8, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 8, 2024

REPL$23.28+4.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Operations

(Amounts in thousands, except share and per share amounts)

Three Months Ended June 30,
20242023
Operating expenses:
Research and development$42,972$40,437
Selling, general and administrative14,39515,211
Total operating expenses57,36755,648
Loss from operations(57,367)(55,648)
Other income (expense):
Research and development incentives438393
Investment income4,7116,186
Interest expense on finance lease liability(534)(544)
Interest expense on debt obligations(1,426)(1,115)
Other income4061,374
Total other income (expense), net3,5956,294
Loss before income taxes$(53,772)$(49,354)
Income tax provision—$201
Net loss$(53,772)$(49,555)
Net loss per common share, basic and diluted$(0.78)$(0.75)
Weighted average common shares outstanding, basic and diluted69,185,88566,367,702
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.